Superinvestor Tracker
← 전체 투자자

ARBUTUS BIOPHARMA CORP

ABUS

보유 투자자

4

합산 평가액

$6.6M

합산 보유 주식 수

1,468,826

현재가

$4.43

52주 최고가

$5.10

52주 최고가 대비

−13.1%

투자자 매매

$2.75$3.59$4.44$5.29Q2'24Q3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26▲2▲3▲2 ▼1▲1 ▼2▲2 ▼1▲2 ▼1▲1 ▼2▲4
매수매도추정 단가분기를 클릭해 거래한 투자자 보기

보유 투자자

투자자평가액포트폴리오 비중평균 매입단가수익률최근 매매기준
Ken Griffin - Citadel Advisors$3.5M0.00%~$4.36+1.6%매수 Q1 2026Q1 2026
Israel Englander - Millennium Management$2.9M0.00%~$4.50−1.6%매수 Q1 2026Q1 2026
Cliff Asness - AQR Capital$107K0.00%~$3.99+11.0%매수 Q1 2026Q1 2026
Joel Greenblatt - Gotham Asset Management$77K0.00%~$4.50−1.6%매수 Q1 2026Q1 2026

최근 매매

분기투자자구분추정 금액추정 단가
Q1 2026Israel Englander - Millennium Management신규 매수+$2.9M~$4.50
Q1 2026Ken Griffin - Citadel Advisors매수+$2.9M~$4.50
Q1 2026Joel Greenblatt - Gotham Asset Management신규 매수+$77K~$4.50
Q1 2026Cliff Asness - AQR Capital매수+$31K~$4.50
Q4 2025Israel Englander - Millennium Management전량 매도−$2.4M~$4.54
Q4 2025Ken Griffin - Citadel Advisors매도−$614K~$4.81
Q4 2025Cliff Asness - AQR Capital매수+$7.5K~$4.81
Q3 2025Ken Griffin - Citadel Advisors매수+$223K~$4.54
Q3 2025Israel Englander - Millennium Management매수+$131K~$4.54
Q3 2025Cliff Asness - AQR Capital매도−$102K~$4.54
Q2 2025Israel Englander - Millennium Management매수+$467K~$3.09
Q2 2025Ken Griffin - Citadel Advisors매수+$39K~$3.09
Q2 2025Cliff Asness - AQR Capital매도−$32K~$3.09
Q1 2025Ken Griffin - Citadel Advisors매도−$506K~$3.49
Q1 2025Israel Englander - Millennium Management매수+$18K~$3.49
Q1 2025Cliff Asness - AQR Capital매도−$1.9K~$3.49
Q4 2024Ken Griffin - Citadel Advisors매도−$1.1M~$3.27
Q4 2024Israel Englander - Millennium Management매수+$301K~$3.27
Q4 2024Cliff Asness - AQR Capital매수+$49K~$3.27
Q3 2024Ken Griffin - Citadel Advisors매수+$1.9M~$3.85
Q3 2024Israel Englander - Millennium Management매수+$161K~$3.85
Q3 2024Cliff Asness - AQR Capital신규 매수+$129K~$3.85
Q2 2024Israel Englander - Millennium Management신규 매수+$645K~$3.09
Q2 2024Ken Griffin - Citadel Advisors신규 매수+$613K~$3.09

보유 현황 추이

분기보유 투자자총 보유 주식 수주식 수 증감총 평가액추정 단가
Q1 202641,468,826+784.2%$6.6M$4.50
Q4 20252166,126−79.8%$799K$4.81
Q3 20253820,664+7.3%$3.7M$4.54
Q2 20253764,957+25.1%$2.4M$3.09
Q1 20253611,304−18.7%$2.1M$3.49
Q4 20243751,811−23.5%$2.5M$3.27
Q3 20243982,422+141.1%$3.8M$3.85
Q2 20242407,444—$1.3M$3.09